LOYOLA UNIVERSITY CHICAGO
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2 is a funding opportunity from LOYOLA UNIVERSITY CHICAGO, up to 732439, closing December 31, 2026.
Dec 31, 2026
(153d left)Overview
TITLE: Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2 PI: Susan C. Baker, PhD, Loyola University Chicago Stritch School of Medicine The goal of this proposal is to determine how viral interferon antagonists function in the replication and pathogenesis of coronaviruses,…